Abstract
Promising potential chemotherapeutics for the treatment of cancer can be developed from farnesyltransferase inhibitors. A novel class of modular bisubstrate farnesyltransferase inhibitors is presented that can be synthesized in a straightforward manner. An example of such an inhibitor is compound 1, which has an IC50 value of 3.7 μM.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have